https://www.selleckchem.com/products/pp2.html
of coelonin and militarine as novel sources for development of treatments for PM2.5-induced lung diseases.The coronavirus disease 2019 (COVID-19) pandemic has become a global health crisis. Considering the recent food and drug administration (FDA) approval of remdesivir as the first officially approved agent for COVID-19 treatment, we performed this systematic review and meta-analysis to evaluate the efficacy and safety of remdesivir administration in COVID-19 patients. A systematic literature search was done through MEDLINE, Google Scholar
Like
Comment
Share
